BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/12/2025 8:18:24 AM | Browse: 157 | Download: 624
 |
Received |
|
2025-03-11 10:10 |
|
Peer-Review Started |
|
2025-03-17 00:46 |
|
First Decision by Editorial Office Director |
|
2025-04-03 04:09 |
|
Return for Revision |
|
2025-04-03 04:09 |
|
Revised |
|
2025-04-17 22:15 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-05-26 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-05-26 07:48 |
|
Articles in Press |
|
2025-05-26 07:48 |
|
Edit the Manuscript by Language Editor |
|
2025-05-31 00:31 |
|
Typeset the Manuscript |
|
2025-08-01 00:56 |
|
Publish the Manuscript Online |
|
2025-08-12 08:18 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Nanoscience & Nanotechnology |
| Manuscript Type |
Minireviews |
| Article Title |
Potential role of nanopharmacology in reducing neuroinflammation associated with hypertension and metabolic disorders
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Virna Margarita Martín Giménez, Sebastián García Menéndez, Raúl Lelio Sanz, Máximo Schiavone, Leon Ferder, Felipe Inserra and Walter Manucha |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación |
PICT 2020 Serie A 4000 |
|
| Corresponding Author |
Walter Manucha, PhD, Professor, Department of Pathology, Instituto de Medicina y Biología Experimental de Cuyo, Consejo Nacional de Investigación Científica y Tecnológica Universidad Nacional de Cuyo, Laboratorio de Farmacología Experimental Básica y Traslacional, Facultad de Ciencias Médicas, Farmacología, Mendoza 5500, Argentina. wmanucha@yahoo.com.ar |
| Key Words |
Neuroinflammation; Nanotechnology/nanopharmacology; Blood-brain barrier; Oxidative stress; Neurodegeneration; Hypertension; Metabolic disorders |
| Core Tip |
This mini-review unveils the intricate nexus between hypertension, metabolic disorders, and neurodegeneration, spotlighting neuroinflammation as a pivotal mediator. To highlight, the compromised cerebral blood flow and blood-brain barrier (BBB) disruption initiate a cascade of oxidative stress and pro-inflammatory cytokine release, culminating in neuronal injury. Crucially, we advocate for the transformative potential of nanopharmacology. Nanoparticle-mediated drug delivery offers a strategic avenue to enhance therapeutic bioavailability and selectivity, enabling targeted intervention across the BBB. By synergizing effective blood pressure management with nanotechnology-driven modulation of neuroinflammation, we pioneer novel strategies to mitigate neurodegenerative pathologies. This paradigm shift holds promise for revolutionizing therapeutic approaches, paving the way for improved patient outcomes in hypertension-associated neurological disorders. |
| Publish Date |
2025-08-12 08:18 |
| Citation |
Martín Giménez VM, García Menéndez S, Sanz RL, Schiavone M, Ferder L, Inserra F, Manucha W. Potential role of nanopharmacology in reducing neuroinflammation associated with hypertension and metabolic disorders. World J Exp Med 2025; 15(3): 106743
|
| URL |
https://www.wjgnet.com/2220-315X/full/v15/i3/106743.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v15.i3.106743 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
